Ads

 

Ads

 

Ads

 

World Top 100 Pharmaceutical Companies List by Market Cap in January 2024

World Top 100 Pharmaceutical Companies List by Market Cap in January 2024, World Biggest 100 Pharmaceutical Companies by Market Cap, World Largest 100 Pharmaceutical Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Pharmaceutical Companies in 2024
Metatag Abstract
World Top Pharmaceutical Companies by Market Cap in 2024, World Largest Pharmaceutical Companies by Market Cap in 2024.
  1. Sawai Pharmaceutical

    World Rank (Jan-05-2024)
    5,467
    World Rank (Jul-30-2023)
    5,467
    World Rank (Dec-25-2022)
    5,467
    World Rank (Jan-07-2022)
    5,467
    Annual Revenue in USD
    1,678 Million USD
    Annual Net Income in USD
    177 Million USD
    Annual Results for Period Ending
    Mar-2020 ending year
    Headquarters Country
  2. Sunflower Pharmaceutical Group

    World Rank (Jan-05-2024)
    5,480
    Market Cap (Jan-05-2024)
    2.122 Billion USD
    World Rank (Jul-30-2023)
    6,041
    Market Cap (Jul-30-2023)
    1.842 Billion USD
    World Rank (Dec-25-2022)
    5,977
    Market Cap (Dec-25-2022)
    1.723 Billion USD
    World Rank (Jan-07-2022)
    7,405
    Market Cap (Jan-07-2022)
    1.51 Billion USD
    Headquarters Country
  3. Shenzhen Hepalink Pharmaceutical Group

    World Rank (Jan-05-2024)
    5,488
    Market Cap (Jan-05-2024)
    2.119 Billion USD
    World Rank (Jul-30-2023)
    5,364
    Market Cap (Jul-30-2023)
    2.220 Billion USD
    World Rank (Dec-25-2022)
    4,757
    Market Cap (Dec-25-2022)
    2.425 Billion USD
    World Rank (Jan-07-2022)
    4,344
    Market Cap (Jan-07-2022)
    3.50 Billion USD
    Annual Revenue in USD
    926 Million USD
    Annual Net Income in USD
    35 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  4. Indivior

    World Rank (Jan-05-2024)
    5,511
    Market Cap (Jan-05-2024)
    2.101 Billion USD
    World Rank (Jul-30-2023)
    4,222
    Market Cap (Jul-30-2023)
    3.140 Billion USD
    World Rank (Dec-25-2022)
    3,930
    Market Cap (Dec-25-2022)
    3.174 Billion USD
    World Rank (Jan-07-2022)
    5,892
    Market Cap (Jan-07-2022)
    2.21 Billion USD
    Annual Revenue in USD
    901 Million USD
    Annual Operating Income in USD
    -91 Million USD
    Annual Net Income in USD
    -53 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Indivior is a global pharmaceutical company working to help change patients lives by pioneering life transforming treatment for substance use disorders and other serious mental illnesses. The company annual revenue is 647 million USD and total assets are 1,531 million USD as on 2020. The headquarters is in UK.

  5. Telix Pharmaceuticals

    World Rank (Jan-05-2024)
    5,516
    Market Cap (Jan-05-2024)
    2.097 Billion USD
    World Rank (Jul-30-2023)
    5,121
    Market Cap (Jul-30-2023)
    2.385 Billion USD
    World Rank (Dec-25-2022)
    6,529
    Market Cap (Dec-25-2022)
    1.510 Billion USD
    World Rank (Jan-07-2022)
    6,854
    Market Cap (Jan-07-2022)
    1.74 Billion USD
    Annual Revenue in USD
    5 Million USD
    Annual Net Income in USD
    -59 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Telix Pharmaceuticals is a late-stage radiopharmaceutical company developing a broad portfolio of diagnostic and therapeutic (‘theranostic’) assets using Molecularly Targeted Radiation (MTR). The company annual revenue is 7 million AUD as on 2021. The headquarters is in Australia.
  6. Neuren Pharmaceuticals

    World Rank (Jan-05-2024)
    5,527
    Market Cap (Jan-05-2024)
    2.090 Billion USD
    World Rank (Jul-30-2023)
    8,222
    Market Cap (Jul-30-2023)
    1.112 Billion USD
    World Rank (Dec-25-2022)
    10,227
    Market Cap (Dec-25-2022)
    0.715 Billion USD
    World Rank (Jan-07-2022)
    15,657
    Market Cap (Jan-07-2022)
    0.36 Billion USD
    Headquarters Country
  7. Yantai Dongcheng Pharmaceutical Group

    World Rank (Jan-05-2024)
    5,579
    Market Cap (Jan-05-2024)
    2.052 Billion USD
    World Rank (Jul-30-2023)
    6,274
    Market Cap (Jul-30-2023)
    1.733 Billion USD
    World Rank (Dec-25-2022)
    5,611
    Market Cap (Dec-25-2022)
    1.900 Billion USD
    World Rank (Jan-07-2022)
    6,201
    Market Cap (Jan-07-2022)
    2.05 Billion USD
    Annual Revenue in USD
    569 Million USD
    Annual Net Income in USD
    22 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  8. Hanmi Science

    World Rank (Jan-05-2024)
    5,618
    Market Cap (Jan-05-2024)
    2.033 Billion USD
    World Rank (Jul-30-2023)
    6,288
    Market Cap (Jul-30-2023)
    1.729 Billion USD
    World Rank (Dec-25-2022)
    5,783
    Market Cap (Dec-25-2022)
    1.813 Billion USD
    World Rank (Jan-07-2022)
    5,012
    Market Cap (Jan-07-2022)
    2.86 Billion USD
    Annual Revenue in USD
    711 Million USD
    Annual Net Income in USD
    32 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Hanmi Pharmaceutical is pharmaceutical company and it is developing and providing innovative drugs to its customers. Headquarters is in South Korea.
  9. Zhejiang Wolwo Bio-Pharmaceutical

    World Rank (Jan-05-2024)
    5,645
    Market Cap (Jan-05-2024)
    2.021 Billion USD
    World Rank (Jul-30-2023)
    4,444
    Market Cap (Jul-30-2023)
    2.917 Billion USD
    World Rank (Dec-25-2022)
    3,406
    Market Cap (Dec-25-2022)
    3.835 Billion USD
    World Rank (Jan-07-2022)
    3,670
    Market Cap (Jan-07-2022)
    4.31 Billion USD
    Annual Revenue in USD
    117 Million USD
    Annual Net Income in USD
    49 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  10. Almirall

    World Rank (Jan-05-2024)
    5,730
    Market Cap (Jan-05-2024)
    1.975 Billion USD
    World Rank (Jul-30-2023)
    6,204
    Market Cap (Jul-30-2023)
    1.770 Billion USD
    World Rank (Dec-25-2022)
    5,953
    Market Cap (Dec-25-2022)
    1.735 Billion USD
    World Rank (Jan-07-2022)
    5,843
    Market Cap (Jan-07-2022)
    2.23 Billion USD
    Annual Revenue in USD
    827 Million USD
    Annual Net Income in USD
    -40 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Almirall is the leading skin health focused global Pharmaceutical company. The company annual revenue is 191.4 million EUR, annual operating income is 6.9 million EUR and total assets are 2,365.7 million EUR as on 2020. The headquarters is in Spain.

Share

Ads